Matos Marshall I MD is categorized under Family Practice Doctors in New Rochelle, NY and active since 1997.
Matos Marshall I MD was established in 1997, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Marshall Matos at the company’s single location by writing to 140 Lockwood Avenue # 310, New Rochelle, New York NY 10801 or by phoning (914) 576-7171. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Matos Marshall I MD |
| Contact Person: | Marshall Matos |
| Address: | 140 Lockwood Avenue # 310, New Rochelle, New York 10801 |
| Phone Number: | (914) 576-7171 |
| Website Address: | lockwoodmedical.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Matos Marshall I MD was started in 1997 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Marshall Matos for inquiries that concern Matos Marshall I MD by calling the company number (914) 576-7171, as your correspondence is most welcome. Additionally, the physical location of the single location of Matos Marshall I MD can be found at the coordinates 40.913324,-73.790589 as well as the street address 140 Lockwood Avenue # 310 in New Rochelle, New York 10801.
For its online presence, you may visit Matos Marshall I MD’s website at lockwoodmedical.com and engage with its social media outlets through on Twitter and on Facebook.